Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 84 | 198 | 411 | 278 | 177 |
| Gross Profit | 84 | 198 | 411 | 278 | 177 |
| Operating Expenses | 12,215 | 11,557 | 8,295 | 7,058 | 7,175 |
| Operating Income | -12,131 | -11,359 | -7,884 | -6,780 | -6,998 |
| Other Income | 1,398 | 1,839 | 1,534 | 192 | 98 |
| Pre-tax Income | -10,733 | -9,520 | -6,350 | -6,588 | -6,900 |
| Income Tax | N/A | -7 | N/A | N/A | 3 |
| Net Income Continuous | -10,733 | -9,513 | -6,350 | -6,588 | -6,903 |
| Net Income | $-10,733 | $-9,521 | $-6,350 | $-6,588 | $-6,903 |
| EPS Basic Total Ops | -0.35 | 0.30 | -0.22 | -0.66 | -0.94 |
| EPS Basic Continuous Ops | -0.35 | 0.30 | -0.22 | -0.66 | -0.94 |
| EPS Diluted Total Ops | -0.35 | 0.30 | -0.22 | -0.66 | -0.94 |
| EPS Diluted Continuous Ops | -0.35 | 0.30 | -0.22 | -0.66 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.25 | -0.22 | -0.66 | N/A |
| EBITDA(a) | $-12,116 | $-11,326 | $-7,853 | $-6,749 | $-6,966 |